A novel inhibitor of activated thrombin-activatable fibrinolysis inhibitor (TAFIa) -Part I: Pharmacological characterization

Journal article

Peer reviewed

Yi-Xin Wang, LEI Zhao, Paul Hrvatin, Judi Bryant, David R Light, Ronald Vergona, John Morser, Brad O Buckman, Mariko Nagashima, Jon Vincelette, …

Thrombosis and haemostasis, Vol.97(1), pp.45-53

2007

PMID: 17200770

Abstract

Biological and medical sciences

Blood coagulation. Blood cells

Fundamental and applied biological sciences. Psychology

Hematologic and hematopoietic diseases

Medical sciences

Molecular and cellular biology

Platelet diseases and coagulopathies

1 Record Views

Title: A novel inhibitor of activated thrombin-activatable fibrinolysis inhibitor (TAFIa) -Part I: Pharmacological characterization
Creators - without role: Yi-Xin Wang - Berlex Bioscience, Richmond, California, United States
LEI Zhao - Bioscience
Paul Hrvatin - Bioscience
Judi Bryant - Bioscience
David R Light - Berlex Bioscience, Richmond, California, United States
Ronald Vergona - Berlex Bioscience, Richmond, California, United States
John Morser - Bioscience
Brad O Buckman - Bioscience
Mariko Nagashima - Berlex Bioscience, Richmond, California, United States
Jon Vincelette - Berlex Bioscience, Richmond, California, United States
Drew Sukovich - Bioscience
WEIWEI LI - Berlex Bioscience, Richmond, California, United States
Babu Subramanyam - Berlex Bioscience, Richmond, California, United States
SHENDONG Yuan - Bioscience
Kumar Emayan - Bioscience
Imadul Islam - Bioscience
Publication Details: Thrombosis and haemostasis, Vol.97(1), pp.45-53
Publisher: Schattauer
Identifiers: 9921645208331
Academic Unit: King Saud Bin Abdulaziz University for Health Sciences
Language: English
Resource Type: Journal article